Cargando…
Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration
Mutations in Frataxin (FXN) cause Friedreich’s ataxia (FRDA), a recessive neurodegenerative disorder. Previous studies have proposed that loss of FXN causes mitochondrial dysfunction, which triggers elevated reactive oxygen species (ROS) and leads to the demise of neurons. Here we describe a ROS ind...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956409/ https://www.ncbi.nlm.nih.gov/pubmed/27343351 http://dx.doi.org/10.7554/eLife.16043 |
_version_ | 1782444027697692672 |
---|---|
author | Chen, Kuchuan Lin, Guang Haelterman, Nele A Ho, Tammy Szu-Yu Li, Tongchao Li, Zhihong Duraine, Lita Graham, Brett H Jaiswal, Manish Yamamoto, Shinya Rasband, Matthew N Bellen, Hugo J |
author_facet | Chen, Kuchuan Lin, Guang Haelterman, Nele A Ho, Tammy Szu-Yu Li, Tongchao Li, Zhihong Duraine, Lita Graham, Brett H Jaiswal, Manish Yamamoto, Shinya Rasband, Matthew N Bellen, Hugo J |
author_sort | Chen, Kuchuan |
collection | PubMed |
description | Mutations in Frataxin (FXN) cause Friedreich’s ataxia (FRDA), a recessive neurodegenerative disorder. Previous studies have proposed that loss of FXN causes mitochondrial dysfunction, which triggers elevated reactive oxygen species (ROS) and leads to the demise of neurons. Here we describe a ROS independent mechanism that contributes to neurodegeneration in fly FXN mutants. We show that loss of frataxin homolog (fh) in Drosophila leads to iron toxicity, which in turn induces sphingolipid synthesis and ectopically activates 3-phosphoinositide dependent protein kinase-1 (Pdk1) and myocyte enhancer factor-2 (Mef2). Dampening iron toxicity, inhibiting sphingolipid synthesis by Myriocin, or reducing Pdk1 or Mef2 levels, all effectively suppress neurodegeneration in fh mutants. Moreover, increasing dihydrosphingosine activates Mef2 activity through PDK1 in mammalian neuronal cell line suggesting that the mechanisms are evolutionarily conserved. Our results indicate that an iron/sphingolipid/Pdk1/Mef2 pathway may play a role in FRDA. DOI: http://dx.doi.org/10.7554/eLife.16043.001 |
format | Online Article Text |
id | pubmed-4956409 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-49564092016-07-28 Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration Chen, Kuchuan Lin, Guang Haelterman, Nele A Ho, Tammy Szu-Yu Li, Tongchao Li, Zhihong Duraine, Lita Graham, Brett H Jaiswal, Manish Yamamoto, Shinya Rasband, Matthew N Bellen, Hugo J eLife Neuroscience Mutations in Frataxin (FXN) cause Friedreich’s ataxia (FRDA), a recessive neurodegenerative disorder. Previous studies have proposed that loss of FXN causes mitochondrial dysfunction, which triggers elevated reactive oxygen species (ROS) and leads to the demise of neurons. Here we describe a ROS independent mechanism that contributes to neurodegeneration in fly FXN mutants. We show that loss of frataxin homolog (fh) in Drosophila leads to iron toxicity, which in turn induces sphingolipid synthesis and ectopically activates 3-phosphoinositide dependent protein kinase-1 (Pdk1) and myocyte enhancer factor-2 (Mef2). Dampening iron toxicity, inhibiting sphingolipid synthesis by Myriocin, or reducing Pdk1 or Mef2 levels, all effectively suppress neurodegeneration in fh mutants. Moreover, increasing dihydrosphingosine activates Mef2 activity through PDK1 in mammalian neuronal cell line suggesting that the mechanisms are evolutionarily conserved. Our results indicate that an iron/sphingolipid/Pdk1/Mef2 pathway may play a role in FRDA. DOI: http://dx.doi.org/10.7554/eLife.16043.001 eLife Sciences Publications, Ltd 2016-06-25 /pmc/articles/PMC4956409/ /pubmed/27343351 http://dx.doi.org/10.7554/eLife.16043 Text en © 2016, Chen et al http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Neuroscience Chen, Kuchuan Lin, Guang Haelterman, Nele A Ho, Tammy Szu-Yu Li, Tongchao Li, Zhihong Duraine, Lita Graham, Brett H Jaiswal, Manish Yamamoto, Shinya Rasband, Matthew N Bellen, Hugo J Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration |
title | Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration |
title_full | Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration |
title_fullStr | Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration |
title_full_unstemmed | Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration |
title_short | Loss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration |
title_sort | loss of frataxin induces iron toxicity, sphingolipid synthesis, and pdk1/mef2 activation, leading to neurodegeneration |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956409/ https://www.ncbi.nlm.nih.gov/pubmed/27343351 http://dx.doi.org/10.7554/eLife.16043 |
work_keys_str_mv | AT chenkuchuan lossoffrataxininducesirontoxicitysphingolipidsynthesisandpdk1mef2activationleadingtoneurodegeneration AT linguang lossoffrataxininducesirontoxicitysphingolipidsynthesisandpdk1mef2activationleadingtoneurodegeneration AT haeltermannelea lossoffrataxininducesirontoxicitysphingolipidsynthesisandpdk1mef2activationleadingtoneurodegeneration AT hotammyszuyu lossoffrataxininducesirontoxicitysphingolipidsynthesisandpdk1mef2activationleadingtoneurodegeneration AT litongchao lossoffrataxininducesirontoxicitysphingolipidsynthesisandpdk1mef2activationleadingtoneurodegeneration AT lizhihong lossoffrataxininducesirontoxicitysphingolipidsynthesisandpdk1mef2activationleadingtoneurodegeneration AT durainelita lossoffrataxininducesirontoxicitysphingolipidsynthesisandpdk1mef2activationleadingtoneurodegeneration AT grahambretth lossoffrataxininducesirontoxicitysphingolipidsynthesisandpdk1mef2activationleadingtoneurodegeneration AT jaiswalmanish lossoffrataxininducesirontoxicitysphingolipidsynthesisandpdk1mef2activationleadingtoneurodegeneration AT yamamotoshinya lossoffrataxininducesirontoxicitysphingolipidsynthesisandpdk1mef2activationleadingtoneurodegeneration AT rasbandmatthewn lossoffrataxininducesirontoxicitysphingolipidsynthesisandpdk1mef2activationleadingtoneurodegeneration AT bellenhugoj lossoffrataxininducesirontoxicitysphingolipidsynthesisandpdk1mef2activationleadingtoneurodegeneration |